Panacea Biotec Receives Azacitidine USFDA Approval For US Market

This is to inform that Panacea Biotec''s Oncology Parenteral Formulation Facility at Baddi, Himachal Pradesh, India, received United States Food & Drug Administration (USFDA) approval for manufacture and supply of Azacitidine Injection, 100 mg/vial, for the US market. Panacea Biotec''s state-of-the-art pharmaceutical formulation facility at Baddi is already approved by National Regulatory Authority (NRA) of India and USFDA for other oral solids and injectable
products.

To read more Press Release articles, click here.